Lifevantage Corporation is in the consumer defensive sector and is in the consumer packaged goods industry. The company CEO is Darren J. Jensen. Lifevantage Corp is engaged in the identification, research, development and distribution of nutraceutical dietary supplements and skin care products including Protandim, LifeVantage TrueScience and Canine Health.



Previous Intraday Performance:

The LFVN shares had a previous change of 2.58% which opened at 11.30 and closed at 11.53. It moved to an intraday high of 11.55 and a low of 11.21.

SeekingAlpha:  LifeVantage Corporation (LFVN) CEO Darren Jensen on Q3 2019 Results – Earnings Call Transcript

Historical Performance:

Over the last five trading days, LFVN shares returned 4.34% and in the past 30 trading days it returned -3.68%. Over three months, it changed -20.26%. In one year it has changed 140.71% and within that year its 52 week high was 17.08 and its 52 week low was 4.80. LFVN stock is 140.21% above its 52 week low.

Our calculations result in a 200 day moving average of 12.71 and a 50 day moving average of 12.22. Right now, LFVN stock is trading -9.28% below its 200 day moving average and may not be a great opportunity to buy as it may continue to trend down.

SeekingAlpha:  LifeVantage Corporation (LFVN) CEO Darren Jensen on Q3 2019 Results – Earnings Call Transcript

Liquidity:

The company has a market cap of $165.3m with 14.3m shares outstanding and a float of 14.3m shares. Trading volume was 74,406 shares and has experienced an average volume of 101,021 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.

Earnings:

The last annual reported EPS for Lifevantage Corporation was 0.41 which ended on 30th of June 2018, which according to the previous close, that is a PE of 28.12. The trailing twelve month EPS reported is 0.50 (trailing twelve month diluted EPS is 0.45).

Below was the last reported quarterly diluted earnings per share:

1stQtr 2019Reported 05-01-2019: 0.12
4thQtr 2018Reported 02-04-2019: 0.06
3rdQtr 2018Reported 11-01-2018: 0.06
2ndQtr 2018Reported 08-15-2018: 0.21
1stQtr 2018Reported 05-09-2018: 0.12

Base on our calculations, the intrinsic value per share is 58.22, which means it might be undervalued and has a margin of safety of 80.20%.

The long-term trend of the EPS is an important number as it indicates the present value of Lifevantage Corporation; it is usually expressed as a percentage and is then referred to as the EPS growth rate, which at this time is hard to estimate, but revenue growth has been 6.40% over the last twelve months.



Indicators Also to Watch:

Based on the latest filings, there is 42.20% of institutional ownership.

The beta was calculated to be 0.61.

SeekingAlpha:  IsoRay EPS in-line, beats on revenue

Fundamental Numbers:

Based on last reported financials, the company’s return on assets is 12.96%, profit margin is 2.97%, price-to-sales is 0.72 and price-to-book is 6.51.

Company Score Card:

Results are out of six:
 2  : Growth Expectations Result
 6  : Financial Safety Result
 3  : Past Performance Result
 2  : Valuation Result
 0  : Dividend Safety Result
 3  : Overall Result

Related Tags: , , ,

Jake McWilliams
I am an independent trader, analyst and algorithmic trading expert, having worked both for the sell side (brokerage) and the buy side (fund administration). I have been trading professionally for about 20 years. I trade stocks and forex and I play both long and short positions in underlying asset or through options. I have experience with discretionary and fully automated systems (Metatrader and Quantshare).

LEAVE A REPLY

Please enter your comment!
Please enter your name here